| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/07/2006 | CN1258366C Chinese medicine composition for treating gynecopathy and its use |
| 06/07/2006 | CN1258365C Pharmaceutical composition for treating cardiovascular and its preparing process |
| 06/07/2006 | CN1258364C Formula of cucurbitacin dripping pills and its preparation method |
| 06/07/2006 | CN1258363C Nimodipine adhesive sheet |
| 06/07/2006 | CN1258361C Breath freshening film |
| 06/07/2006 | CN1258360C Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 06/07/2006 | CN1258359C Pharmaceutical compositions |
| 06/07/2006 | CN1258358C Polymeric micelle composition |
| 06/06/2006 | US7057189 Monochromatic fluid treatment systems |
| 06/06/2006 | US7056957 Formation of strong superporous hydrogels |
| 06/06/2006 | US7056951 Stabilizers to inhibit the formation of a lactam, comprising a composition that is known to reduce ionic activity (such as an alcohol, ketone, stearate or cellulose derivative); and at least 20 ppm of an anion. |
| 06/06/2006 | US7056936 Synergistic combination |
| 06/06/2006 | US7056901 Microgel particles for the delivery of bioactive materials |
| 06/06/2006 | US7056898 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 06/06/2006 | US7056893 Topical treatment for prevention of ocular infections |
| 06/06/2006 | US7056887 Treatment of acute coronary syndrome with GLP-1 |
| 06/06/2006 | US7056886 GLP-2 formulations |
| 06/06/2006 | US7056726 membrane for encapsulation chamber of cells producing at least a biologically active substance and bioartificial organ comprising same |
| 06/06/2006 | US7056704 RNA interference mediating small RNA molecules |
| 06/06/2006 | US7056554 Production of polyelectrolyte capsules by surface precipitation |
| 06/06/2006 | US7056539 Synergistic herbal combination |
| 06/06/2006 | US7056535 Triggered release from proteinoid microspheres |
| 06/06/2006 | US7056534 having a continuous coating consisting of a single thermoplastic cellulose ether, particularly ethyl cellulose, for extended release |
| 06/06/2006 | US7056533 Medicament incorporation matrix |
| 06/06/2006 | US7056532 supramolecular complex of an uncrosslinked block polymer having a nonionic, water soluble segment and a polyanionic segment, and a hydrophobic surfactant having a charge opposite to the charge of the polymer; increased bioavailability; decreased side effects; site-specific drug delivery |
| 06/06/2006 | US7056531 Sustained release compositions for orally administered substances and methods |
| 06/06/2006 | US7056530 Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities |
| 06/06/2006 | US7056529 Vesicle comprises ATP and phospholipid; fusion proteins |
| 06/06/2006 | US7056528 Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin |
| 06/06/2006 | US7056527 Patches containing buprenorphine hydrochloride |
| 06/06/2006 | US7056526 Medical adhesive composition, medical adhesive tape using the same and tape preparation for percutaneous absorption |
| 06/06/2006 | US7056525 Use thereof in human and animal foods, cosmetics and pharmaceuticals; soft gelatin capsules |
| 06/06/2006 | US7056524 Methods of hydrating mucosal surfaces |
| 06/06/2006 | US7056503 Antigrowth agents; solid support releasing protein |
| 06/06/2006 | US7056495 Vehicle for amorphus drug dose delivery, containing a hydrophobic material and a polyol; dissolving the polyol and hydrophobic bioactive material in an organic/aqueous solvent, removing the solvent and forming the vehicle |
| 06/06/2006 | US7056494 Method of treating a systemic disease |
| 06/06/2006 | US7056493 Radio-opaque polymer biomaterials |
| 06/06/2006 | US7056377 For the production of capsules and coatings for solid formulations in drug, cosmetic, food and dietetic fields, and for coating seeds. |
| 06/06/2006 | US7056332 making a suture by modifying an aqueous suspension of a nucleic acid, e.g., by capping, crosslinking, methylation, ethylation, or attachment of a protein, to form a viscous gel, which is extruded to form a filament; optionally adding a biodegradable polymer |
| 06/06/2006 | US7056316 Valve port and method for vascular access |
| 06/06/2006 | US7056118 Compositions and devices having a tray-like configuration for delivering a medicament and methods of manufacturing and using such compositions and devices |
| 06/06/2006 | CA2457852C Multivesicular emulsion topical delivery systems |
| 06/06/2006 | CA2449892C Nutritional supplement to treat macular degeneration |
| 06/06/2006 | CA2417686C Manufacture of oral dosage forms delivering both immediate release and sustained release drugs |
| 06/06/2006 | CA2376706C Antifungal oral composition containing itraconazole and process for preparing same |
| 06/06/2006 | CA2339935C External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
| 06/06/2006 | CA2242577C Skin-adhering pharmaceutical preparation, in particular transdermal therapeutic system for the release of 17-.beta.-estradiol to the human organism |
| 06/06/2006 | CA2171303C Active principles and gas containing microparticles |
| 06/06/2006 | CA2160775C Transdermal therapeutic system containing estradiol |
| 06/01/2006 | WO2006058318A2 Topical nitric oxide donor devices |
| 06/01/2006 | WO2006058250A2 Orally disintegrating compositions |
| 06/01/2006 | WO2006058249A2 Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| 06/01/2006 | WO2006058247A2 Dosage forms and methods of use thereof |
| 06/01/2006 | WO2006058109A1 Triple natural polymer viscoelastic composition |
| 06/01/2006 | WO2006058059A2 Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject |
| 06/01/2006 | WO2006057903A2 Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide |
| 06/01/2006 | WO2006057823A1 Ophthalmic compositions comprising polyether substituted polymers |
| 06/01/2006 | WO2006057637A1 Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof |
| 06/01/2006 | WO2006057429A1 Method of changing morphology of block copolymer |
| 06/01/2006 | WO2006057375A1 Medicinal preparation for external use |
| 06/01/2006 | WO2006057374A1 Method for preparing composite fine particles |
| 06/01/2006 | WO2006057194A1 Solid agent and process for producing the same |
| 06/01/2006 | WO2006056812A1 Dry powder inhaler formulations comprising surface-modified particles with anti- adherent additives |
| 06/01/2006 | WO2006056770A1 Extended release pharmaceutical composition of celecoxib |
| 06/01/2006 | WO2006056713A1 Solid, oral, microparticulate dosage form which has been designed to prevent misuse |
| 06/01/2006 | WO2006056712A1 Solid, oral drug form which has been designed to prevent misuse |
| 06/01/2006 | WO2006056711A2 Oral medicament for the modified release of at least one active principle, in multimicrocapsule form |
| 06/01/2006 | WO2006056362A2 Delivery vehicle manufactured by the miniemulsion method |
| 06/01/2006 | WO2006056357A1 Additive for domestic washing processes |
| 06/01/2006 | WO2006056312A1 Stable crystalline modifications of dotap chloride |
| 06/01/2006 | WO2006056306A2 Hydrogel polymeric conjugates of a prodrug |
| 06/01/2006 | WO2006056204A1 Method of cross-linking hyaluronic acid with divinylsulfone |
| 06/01/2006 | WO2006056145A2 Osmotic device containing a venlafaxine salt and a salt having a common ion |
| 06/01/2006 | WO2006056144A2 Osmotic device containing licofelone |
| 06/01/2006 | WO2006056079A1 Formulations of pyridoxal -5'-phosphate and methods of preparation |
| 06/01/2006 | WO2006056078A1 Novel formulation of pyridoxal 5'-phosphate and method of preparation |
| 06/01/2006 | WO2006056064A1 Solid formulations of liquid biologically active agents |
| 06/01/2006 | WO2006056042A1 Nsaid compositions exhibiting clinical superiority |
| 06/01/2006 | WO2006041878A3 Primary examiner |
| 06/01/2006 | WO2006040596A3 Compositions for intranasal administration |
| 06/01/2006 | WO2006037116A3 Semi-solid delivery vehicle and pharmaceutical compositions |
| 06/01/2006 | WO2006032762A3 Pharmaceutical composition comprising a solid dispersion with a polymer matrix containing a continuous polydextrose phase and a continuous phase of a polymer other than polydextrose |
| 06/01/2006 | WO2006032043A3 Lubricious compounds for biomedical applications using hydrophilic polymers |
| 06/01/2006 | WO2006031848A3 Corticosteroid topical dispersion with low content of surfactant |
| 06/01/2006 | WO2006031271A3 Pharmaceutically elegant, topical anhydrous aerosol foam |
| 06/01/2006 | WO2006028831A3 Compositions comprising 5-amino-2-hydroxybenzoic acid and a reducing sugar |
| 06/01/2006 | WO2006020720A3 Stable pegylated interferon formulation |
| 06/01/2006 | WO2006018295A3 Nanotransport system having a dendritic architecture |
| 06/01/2006 | WO2005117905A3 Systems and methods for treating panic attacks |
| 06/01/2006 | WO2005112895A3 Ingestible device platform for the colon |
| 06/01/2006 | WO2005112882A3 Pharmaceutical compositions |
| 06/01/2006 | WO2005099667A3 Drug delivery compositions |
| 06/01/2006 | WO2005097196A3 Pharmaceutical preparation containing drospirenone for application to the skin |
| 06/01/2006 | WO2005070390A3 Mitratapide oral solution |
| 06/01/2006 | WO2005069886A3 Sparsely cross-linked nanogels: a novel polymer structure for microchannel DNA sequencing |
| 06/01/2006 | WO2005014046A3 Compositions for delivery of therapeutics into the eyes and methods for making and using the same |
| 06/01/2006 | WO2005009602A3 Capped mesoporous silicates |
| 06/01/2006 | WO2004091550A3 Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives |
| 06/01/2006 | US20060116665 Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel |
| 06/01/2006 | US20060116664 Automatic conveyor driven by hydrogels, provided with an adjustable output characteristic for conveying a medium |